Abstract:Background D‐dimer is involved in poor outcomes of stroke as a coagulation biomarker. We aimed to investigate the associations of the level and increase in D‐dimer between baseline and 90 days with all‐cause death or poor functional outcome in patients after ischemic stroke or transient ischemic attack. Methods and Results We collected data from the CNSRIII (Third China National Stroke Registry) study. The present substudy included 10 518 patients within 7 days (baseline) of ischemic stroke or transient ischemic attack and 6268 patients at 90 days. Poor functional outcome at 1 year was assessed on the basis of the modified Rankin Scale (≥3). Multivariable Cox regression or logistic regression was used to assess the association of D‐dimer levels with all‐cause death or poor functional outcome. D‐dimer levels at 90 days were lower than those at baseline (1.4 μg/mL versus 1.7 μg/mL; P <0.001). Higher baseline D‐dimer level was associated with all‐cause death (adjusted hazard ratio [HR], 1.77; 95% CI, 1.25–2.52; P =0.001) and poor functional outcome (adjusted odds ratio [OR], 1.49; 95% CI, 1.23–1.80; P <0.001) during 1‐year follow‐up. Higher D‐dimer level at 90 days was also associated with poor outcomes independently. Furthermore, an increase in D‐dimer levels between baseline and 90 days was associated with all‐cause death (since 90 days to 1 year after index event) (adjusted HR, 1.99; 95% CI, 1.12–3.53; P =0.019) but not with poor functional outcome (adjusted OR, 1.08; 95% CI, 0.82–1.41). Conclusions Our study shows that high level and an increase in D‐dimer between baseline and 90 days are associated with poor outcomes in patients after ischemic stroke or transient ischemic attack. Nonstandard Abbreviations and Acronyms CNSRIII Third China National Stroke Registry mRS modified Rankin Scale NIHSS National Institutes of Health Stroke Scale TOAST Trial of Org 10172 in Acute Stroke Treatment Clinical Perspective What Is New? Baseline and 90‐day D‐dimer levels were associated with all‐cause death and poor functional outcome in a large population with ischemic stroke or transient ischemic attack. An increase in D‐dimer levels was associated with all‐cause death after ischemic stroke or transient ischemic attack. What Are the Clinical Implications? Dynamic measurements of D‐dimer levels might be helpful for identifying patient with stroke or transient ischemic attack at a higher risk of recurrent events. It is uncertain if patients with stroke or transient ischemic attack and an elevated D‐dimer may benefit from more aggressive antithrombotic or anticoagulant measures for secondary stroke prevention. Cerebrovascular disease is the leading cause of death and disability in China, with the majority of cases (69.6%–70.8%) involving ischemic stroke and transient ischemic attack (TIA). 1 , 2 Identifying potential risk factors of poor outcomes and developing targeted therapeutics are critical. In particular, we recently reported that lipid metabolism and inflammatory factors were associated with stroke outcomes. 3 , 4 , 5 D‐dimer, which is a fibrin degradation product, is a biomarker for coagulation and reflects increased thrombosis. 6 , 7 Although D‐dimer level has been clearly confirmed to be associated with death in the general population in the long term, 8 , 9 only a few studies assessed the association of D‐dimer with death 10 , 11 , 12</s -Abstract Truncated-

The role of the D-dimer to fibrinogen ratio in the classification of cardioembolism and atherosclerotic stroke

D-Dimer to Fibrinogen Ratio As a Novel Prognostic Marker in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.

A Retrospective Cohort Study on a Novel Marker to Predict the Severity and Prognosis of Acute Cerebral Venous Thrombosis: D-dimer to Fibrinogen Ratio

Emergency admission plasma D-dimer and Prothrombin activity in acute ischemic stroke with large artery occlusion

Plasma D-Dimer Predicts Short-Term Poor Outcome after Acute Ischemic Stroke

The value of D-dimer to lymphocyte ratio in predicting clinical outcomes after percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: A retrospective study

Evaluation of analytic and clinical performance of thrombin-antithrombin complex andd-dimer assay in prognosis of acute ischemic stroke

Plasma Level of D-dimer is an Independent Diagnostic Biomarker for Deep Venous Thrombosis in Patients with Ischemic Stroke

D-dimer As a Biomarker for Acute Aortic Dissection

Clinical significance of D-dimer and fibrinogen in early diagnosis of coronary heart disease

Elevated D-Dimer Levels Correlate with the Development of Hepatorenal Syndrome and a Poor Outcome in Patients with Cirrhosis

Impact of D-dimer on the outcomes of endovascular thrombectomy for acute ischemic stroke: A systematic review and meta-analysis

The value of combined detection D-dimer and NLR in judging the severity and short-term prognosis of acute cardiogenic cerebral embolism in elderly patients

The use of d-dimer in the diagnosis and risk assessment of intracardiac thrombus among patients with dilated cardiomyopathy

Differences in D-dimer Blood Concentration in Atrial Fibrillation Patients with Left Atrial Thrombus or Severe Left Atrial Spontaneous Echo Contrast

A Systematic Review of the Predictive Value of Plasma D-Dimer Levels for Predicting Stroke Outcome

Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.

D-dimer Level Predicts In-Hospital Adverse Outcomes after Primary PCI for ST-segment Elevation Myocardial Infarction.

D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis

Association Between Coagulation Function and Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation And/or Rheumatic Heart Disease.

The Relationship Between Fibrinogen and Its Degradation Products and D-dimer with Acute Cerebrovascular Disease